Plasma and Erythrocyte Glutathione and Vitamin E in Preterm Infants at Risk for Bronchopulmonary Dysplasia

2013 ◽  
Vol 24 (1) ◽  
pp. 99-106
Author(s):  
Sayed Abu El Makarem ◽  
Ola Abdelwahab Hamed ◽  
Soher A. M. Ismail
2021 ◽  
Author(s):  
Kentaro Tamura ◽  
Mitsuhide Nagaoka ◽  
Satomi Inomata ◽  
Yukako Kawasaki ◽  
Masami Makimoto ◽  
...  

Abstract Systemic hydrocortisone administration has been widely used in preterm infants who are at a risk of bronchopulmonary dysplasia (BPD). However, the effects of hydrocortisone on cytokine profiles have not been examined. We aimed to investigate the effects of postnatal hydrocortisone treatment on serum cytokine levels in extremely preterm infants at risk for BPD. In 29 extremely preterm infants (born at less than 28 weeks of gestational age), we obtained serum from blood samples collected during an early phase (5–20 days) and a late phase (28‒60 days) after birth. We measured the levels of proinflammatory cytokines (tumor necrosis factors α and β, interleukin [IL]-1β, and IL-6), T-helper (Th) 1 cytokines (interferon-γ, IL-2, and IL-12p70), Th2 cytokines (IL-4, IL-5, and IL-10), Th17 cytokine IL-17A, and chemokine IL-8. We found that serum IL-6 and IL-8 levels were significantly higher during the early phase than during the late phase (both P = 0.03). Other cytokines concentrations did not change between the phases. Thirteen infants (45%) received systemic hydrocortisone treatment at a median age of 15 days (IQR 10.0–21.5) after birth due to respiratory deterioration, after which the serum IL-6 levels significantly decreased (P = 0.04). Median duration of treatment was 16.0 (IQR 8.0–34.5) days. Conclusion: Extremely preterm infants show high serum IL-6 and IL-8 levels in the early phase of life. Moreover, postnatal systemic hydrocortisone treatment might suppress IL-6 overproduction.


2011 ◽  
Vol 30 (5) ◽  
pp. 379-383 ◽  
Author(s):  
Tae-Jung Sung ◽  
Li Xiao ◽  
Lynn Duffy ◽  
Ken B. Waites ◽  
Kirsty L. Chesko ◽  
...  

2009 ◽  
Vol 79 (56) ◽  
pp. 288-296 ◽  
Author(s):  
Annelies Vogelsang ◽  
Richard A. van Lingen ◽  
Janine Slootstra ◽  
Bert D. Dikkeschei ◽  
Boudewijn J. Kollen ◽  
...  

Objectives: Oxidative stress is implicated in the pathogenesis of bronchopulmonary dysplasia (BPD) and consequently, it might be theorized that sufficient antioxidant defenses are needed to prevent BPD. We hypothesized that, except for vitamins E and A, carotenoids may be important in this defense. Carotenoids are present in human milk; however, they are not added to parenteral nutrition, the main food source of preterm infants in the first week of life. Aim: To evaluate prospectively the role of carotenoids in BPD in a cohort of preterm infants. Methods: The plasma concentrations of F2α-isoprostane, α- and β-carotene, lycopene, lutein, vitamin A, and the vitamin E/cholesterol ratio were studied at days 1, 3, and 7 in a cohort of 109 preterm infants, of whom 19 had BPD. Results: When comparing the BPD and control group, infants in the BPD group were younger (p<0.001) and β-carotene (day 7, p<0.01) and vitamin A concentrations were lower (days 3 and 7, p<0.001). Lycopene, lutein, α-carotene, vitamin E, and F2α-isoprostane concentrations did not differ between groups. Conclusions: Plasma β-carotene and vitamin A concentrations are lower in BPD infants which may result in a reduction of their antioxidant protection.


2021 ◽  
Author(s):  
Haiyan Ge ◽  
Weina Liu ◽  
Huimin Li ◽  
Ming Zhang ◽  
Mengbin Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document